Targeting Picornavirus Nonstructural 2C Protein: Structure, Function, and Antiviral Discovery

IF 4.5 2区 医学 Q2 CHEMISTRY, MEDICINAL
ACS Infectious Diseases Pub Date : 2026-08-14 Epub Date: 2026-07-27 DOI:10.1021/acsinfecdis.6c00387
Kan Li, Guangjin Fan, Wenyi Zhang, Jun Wang
{"title":"Targeting Picornavirus Nonstructural 2C Protein: Structure, Function, and Antiviral Discovery","authors":"Kan Li,&nbsp;Guangjin Fan,&nbsp;Wenyi Zhang,&nbsp;Jun Wang","doi":"10.1021/acsinfecdis.6c00387","DOIUrl":null,"url":null,"abstract":"<p>Picornaviruses cause\r\nsubstantial human and veterinary disease,\r\nyet direct-acting antivirals remain limited. The nonstructural protein\r\n2C is among the most conserved picornaviral proteins and has ATPase\r\nand helicase-like activities. 2C is involved in membrane remodeling,\r\nRNA replication, encapsidation, morphogenesis, and multiple virus–host\r\ninteractions. In this review, we summarize the domain architecture\r\nand structural biology of 2C, highlighting the N-terminal membrane-binding\r\nregion, the ATPase core, the C-terminal helical domain, and accessory\r\nmotifs that regulate oligomerization and ligand recognition. We further\r\nreview experimentally supported roles of 2C throughout the viral replication\r\ncycle and compare known inhibitors, resistance mutations, and emerging\r\ndesign strategies. Collectively, current evidence supports 2C as a\r\ntractable yet still underexploited antiviral target for medically\r\nimportant picornaviruses.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 8","pages":"2505–2528"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00387","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Picornaviruses cause substantial human and veterinary disease, yet direct-acting antivirals remain limited. The nonstructural protein 2C is among the most conserved picornaviral proteins and has ATPase and helicase-like activities. 2C is involved in membrane remodeling, RNA replication, encapsidation, morphogenesis, and multiple virus–host interactions. In this review, we summarize the domain architecture and structural biology of 2C, highlighting the N-terminal membrane-binding region, the ATPase core, the C-terminal helical domain, and accessory motifs that regulate oligomerization and ligand recognition. We further review experimentally supported roles of 2C throughout the viral replication cycle and compare known inhibitors, resistance mutations, and emerging design strategies. Collectively, current evidence supports 2C as a tractable yet still underexploited antiviral target for medically important picornaviruses.

靶向小核糖核酸病毒非结构2C蛋白:结构、功能和抗病毒发现
小核糖核酸病毒引起大量人类和兽医疾病,但直接作用的抗病毒药物仍然有限。非结构蛋白2C是最保守的小核糖核酸病毒蛋白之一,具有atp酶和解旋酶样活性。2C参与了膜重塑、RNA复制、衣壳化、形态发生和多种病毒-宿主相互作用。在这篇综述中,我们总结了2C结构域的结构和结构生物学,重点介绍了n端膜结合区、atp酶核心、c端螺旋结构域以及调节寡聚化和配体识别的辅助基序。我们进一步回顾了实验支持的2C在整个病毒复制周期中的作用,并比较了已知的抑制剂、抗性突变和新兴的设计策略。总的来说,目前的证据支持2C是治疗医学上重要的小核糖核酸病毒的一种可处理但仍未充分利用的抗病毒靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Infectious Diseases
ACS Infectious Diseases CHEMISTRY, MEDICINALINFECTIOUS DISEASES&nb-INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.80%
发文量
213
期刊介绍: ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to: * Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials. * Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets. * Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance. * Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents. * Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota. * Small molecule vaccine adjuvants for infectious disease. * Viral and bacterial biochemistry and molecular biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书